Francisco Javier Oliver (F J Oliver, F Javier Oliver)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 15

Top Venues

Cell death & disease

Cancers

Journal of experimental & clinical cancer research : CR

The Journal of pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Francisco Javier Oliver, María Victoria Vargas Padilla, Laura Lobo-Selma, Antonio Chacón-Barrado, Juan Díaz Martín, Enrique de Álava
VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation. International journal of molecular sciences 24 (11) (2023)
Ana Belén Herrera-Campos, Esteban Zamudio-Martinez, Daniel Delgado-Bellido, Mónica Fernández-Cortés, Luis M Montuenga, Francisco Javier Oliver, Angel Garcia-Diaz
Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System. Cancers 14 (11) (2022)
Mónica Fernández-Cortés, Daniel Delgado-Bellido, Eloísa Bermúdez-Jiménez, Jesús M Paramio, Francisco O'Valle, Stefan Vinckier, Peter Carmeliet, Angel Garcia-Diaz, Francisco Javier Oliver
PARP inhibition promotes endothelial-like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry. The Journal of pathology (2022)
Jara Majuelos-Melguizo, José Manuel Rodríguez-Vargas, Nuria Martínez-López, Daniel Delgado-Bellido, Ángel García-Díaz, Víctor J Yuste, Marina García Macia, Laura M López, Rajat Singh, Francisco Javier Oliver
Glioblastoma Cells Counteract PARP Inhibition through Pro-Survival Induction of Lipid Droplets Synthesis and Utilization. Cancers 14 (3) (2022)
Esteban Zamudio-Martinez, Ana Belén Herrera-Campos, Alberto Muñoz, José Manuel Rodríguez-Vargas, Francisco Javier Oliver
Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
José-Manuel Rodriguez-Vargas, Kathline Martin-Hernandez, Wei Wang, Nicolas Kunath, Rajikala Suganthan, Jean-Christophe Amé, Francisco Javier Oliver, Jing Ye, Magnar Bjørås, Françoise Dantzer
Parp3 promotes astrocytic differentiation through a tight regulation of Nox4-induced ROS and mTorc2 activation. Cell death & disease 11 (11) (2020)
Mónica Fernández-Cortés, Eduardo Andrés León, Francisco Javier Oliver
The PARP Inhibitor Olaparib Modulates the Transcriptional Regulatory Networks of Long Non-Coding RNAs during Vasculogenic Mimicry. Cells 9 (12) (2020)

Francisco Javier Oliver.css-eqlu8i{font-size:small;padding-left:4px;} (F J Oliver, F Javier Oliver)

Publication Activity (10 Years)

Top Topics

Top Venues

Francisco Javier Oliver (F J Oliver, F Javier Oliver)